Kim OH, Kwon BS, et al. Association between duration of aminoglycoside treatment and outcome of cavitary Mycobacterium avium complex lung disease. Clin Infect Dis. 2019; 68(11): 1870-1876. View PubMed(상세보기)

Kim OH, Kyung-Wook Jo, et al. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection. PLoS One. 2020;15(6): e0234700. View PubMed(상세보기)

Kwon YS, Han MK, Kwon BS, Kim OH, et al. Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: A propensity score analysis. J Glob Antimicrob Resist. 2020; 22: 106-112. View PubMed(상세보기)

Kwon YS, Kwon BS, Kim OH, et al. Treatment outcomes after discontinuation of ethambutol due to adverse events in Mycobacterium avium complex lung disease. J Korean Med Sci. 2020; 35(9): e59. View PubMed(상세보기)

Park YE, Chong YP, Kim YJ, Kim OH, et al. Outcome of shorter treatment duration in non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease. J Thorac Dis. 2020; 12(3): 338-348. View PubMed(상세보기)

Han DW, Jo KW, Kim OH, Shim TS. Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Respir Med. 2021; 179: 106340.7) View PubMed(상세보기)